Figure 2
Effects of RES treatment on final tumor weight (A) and volume (B, C) in HepG2 cell variant xenografts. CAV1, CAVM1, CAVM2, CAVRNAi and HepG2 cells (5 × 106 cells/0.2 ml) were implanted subcutaneously into the back of Balb/c-nu female mice on day 0. RES treatment (15 mg/kg body) was started ten days after implantation. The tumor volume was calculated every 2 to 3 day. Values represent means × SEM, n = 4. a. P < 0.05 vs. control group. b. P < 0.05 vs. corresponding untreated group.